The UK’s pharma deal was vital – but the GSK boss is right about US dominance | Nils Pratley
That’s gratitude, eh? It’s not even a fortnight since the government agreed to raise the prices the NHS pays for new medicines and here comes the boss of GSK, Britain’s second largest pharma firm, to extol the virtues of doing business in the US.The US is “still the leading market in the world in terms of the launches of new drugs and vaccines”, said the chief executive, Emma Walmsley, in a BBC interview, explaining why GSK invests about three times as much over there as it does at home.Alongside China, the US is also “the best market in the world to do business development”.Her comments have caused a stir but, actually, are merely a statement of reality.It would be absurd to pretend the UK has suddenly shot to the top of the competitiveness table in life sciences as a result of the multipronged price and tariffs deal at the start of this month.
Yes, the UK retains excellent research facilities, links with universities and other soft “ecosystem” benefits – successive governments’ boasts about the UK being a life sciences “superpower” are not wholly fanciful,But the US remains streets ahead in terms of what it spends on new drugs, the depth of its research and manufacturing bases and the funding its startups and biotech businesses can raise,That’s just how things are,But, as Walmsley also said, this month’s deal on NHS prices and tariffs is welcome,Critics complain the terms represent a capitulation to big pharma and Trump.
But what else was the government supposed to do? If it is serious about the “superpower” stuff, it had to avert tensions that existed long before the president threatened to impose tariffs at nose-bleed rates on UK pharma exports to the US,Quarrels over NHS pricing were plainly related to lost investments in the UK, such as Merck’s scrapping of a £1bn research centre in London,One issue was the complicated “voluntary” price scheme, which tries to promote innovation while protecting the NHS budget via a cap,Companies’ rebate payments have been unpredictable and last year’s tally was 23% of sales, far above comparable rates in other large European countries,The other issue is the price the National Institute for Health and Care Excellence (Nice) allows the NHS to spend on life-extending drugs.
The deal wrapped the items together.The UK got zero tariffs on exports to the US for three years.The price rebate was capped at 15%.And Nice raised its baseline price thresholds by 25% at the lower end.Cue the complaints about NHS budgets being diverted from frontline equipment and hospitals.
Yes, that is undeniably a risk: the health service’s spending on pharmaceuticals will rise by £3bn a year.But the alternative was less investment in the UK, which might create even more pressure on budgets over time and even less access for patients to new medicines.In a world of trade-offs, and from a tricky negotiating position, the government looks to have landed in roughly the right spot.A deal had to happen, as argued here many times.Walmsley called it “a step in the right direction”, which is positive but not a five-star review.
That is probably also fair.The plan is for the UK to double to 0.6% the percentage of GDP spent on new medicines over a decade, which leaves plenty of time for tensions to flare again.Meanwhile, the terms of the post-2029 “voluntary” scheme also have to be negotiated.But other projects are happening in the wings, such as the £600m-backed Health Data Research Service, which aims to “turbocharge access to NHS data for researchers” by exploiting the health service’s strength as a unified system.
At a time when the government’s industrial strategy seems to be moving in slow motion on several fronts, the position in life sciences could easily have been worse.It’s just that the pull of US will, undeniably, remain strong.
Littler lights up Ally Pally opening night as prize money raises stakes
The PDC world darts championship is back, but could the new £1m winners’ cheque make this show too big?A team of assistant referees walks into the Twelve Pins in Finsbury Park carrying linesmen’s flags and whistles. It’s 3pm on a Thursday, you think, they’ve probably just been reffing a local game. Then, you think, there isn’t a football pitch around here. And why haven’t they changed and showered? Then more referees walk in, more linesmen, one of them in a comedy wig. And eventually the penny drops
Leinster’s Leo Cullen will use lessons learned at Leicester in bid to tame Tigers
Leicester v Leinster fixtures have become common recently – the fifth since 2022 takes place on Friday night – but the history between the sides runs far deeper. Leo Cullen, head coach of the Dublin-based province, spent a couple of seasons at Welford Road in the mid-2000s, winning the Premiership in 2006-07 and losing a Heineken Cup final against Wasps in the same season.Since 2022 the former second‑row has overseen four Champions Cup victories against his former club, including two in 2023-24. Three and a half years ago, there was a masterful quarter-final dismantling of what was then Steve Borthwick’s side. Leinster will now shoot for a hat-trick of Welford Road victories this decade, and the presence of the New Zealand international Rieko Ioane, on full debut, is sure to help
Can a nepo baby be an underdog? The remarkable rise of Shedeur Sanders
The quarterback was seen as living off his father’s name when he entered the NFL. But he has slowly started to prove himself at the Cleveland BrownsIt seems the goalposts are always moving on Shedeur Sanders, the Cleveland Browns’ rookie quarterback who keeps throwing people off.He excelled at two colleges to establish himself as a top NFL prospect, only to wind up getting picked in the fifth round of this year’s NFL draft in one of the most dramatic stock crashes in league history. He then distinguished himself in training camp, only to wind up as the back-up to the back-up. When Sanders was finally pressed into injury relief duty last month and led the Browns to just their third win of the season, the caveat was that his breakthrough had come at the expense of the even-worse Las Vegas Raiders
‘The netball mum community has been insane’: England captain Nat Metcalf on her return to action
Receiving her first centre pass at London’s Copper Box Arena will be an unforgettable moment for the skipperA gurgle turns into a squawk, and the early throes of a weary cry – sure-fire signs that an afternoon nap is required. For much of her life, since her dramatic arrival in the pre-dawn hours of a May morning, the seven-month-old Miller has been a regular presence at England netball camps.Sometimes she sleeps courtside, other times watches from a balcony, or is passed between arms of players and staff members eagerly seeking a cuddle during team meetings. Whatever it takes for her mother, the England netball captain, Nat Metcalf, to get back on court.When Metcalf pulls on her England dress against Jamaica on Saturday, returning to competition for the first time since giving birth, Miller will be there, just as she always is
Sports Personality of the Year 2025: Lionesses square off on six-strong shortlist
Three world champions, two European champions and the holder of a grand slam will face off next Thursday for the title of BBC Sports Personality of the Year, in a shortlist that provides a high-powered boost to the venerable prize show.Following a triumphant summer for England’s women in both football and rugby, Chloe Kelly and Hannah Hampton of the Lionesses are nominated, as is the Red Roses’ Ellie Kildunne. They are joined in the six-person shortlist by Formula One champion Lando Norris, darts world champion Luke Littler and Masters champion Rory McIlroy, the bookies’ favourite.Kelly and Hampton were at the centre of England’s penalty shootout win over Spain in the Euro 2025 final, with Kelly scoring the winning spot-kick after Hampton had made two critical saves. For their club sides, Kelly was part of Arsenal’s Champions League winning team, while Hampton won a domestic treble with Chelsea
‘It can be brutal’: Gian van Veen learns to fly with the stars after dartitis
Dutch rising star has gone from not knowing ‘how to grip the dart’ to a dark horse for the PDC world championshipIt’s the deciding leg of the European Championship final. Gian van Veen, the 23-year-old from the Netherlands chasing his first major title, has just missed two match darts to win 11-9. Luke Humphries, world No 1 at the time, starts the final leg with a 140.“Oh, you’ve blown it here,” Van Veen replies when asked to describe his internal monologue during that moment in October. “Luke Humphries is not going to crumble under this pressure
Dragon’s teeth and elf garden among 2025 additions to English heritage list
Jimmy Kimmel on Trump: ‘What a child he is’
Discover Australia’s top 50 children’s picture books as nominated by Guardian readers
Jon Stewart on Fifa’s peace prize: ‘An entirely fictitious golden butt plug’
Joyful, irreverent, endlessly quotable: why Hunt for the Wilderpeople is the perfect holiday movie
‘True activism has to cost you something’: Bridgerton’s Nicola Coughlan on politics, paparazzi and parasocial fandom